Sign in
4

Changes in Ownership

Mineralys Therapeutics, Inc. Filed Acc 0001672659-26-000020

Chief Medical Officer sold 2,170 shares at $27.38 ($59,415)

  • Chief Medical Officer acquired 2,170 shares (option exercise)
  • Traded under a Rule 10b5-1 plan

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Rodman David Malcom Chief Medical Officer 2026-04-09 Option exercise 10b5-1 +2,170 $16.00 $34,720 78,310 D
Rodman David Malcom Chief Medical Officer 2026-04-09 Sale 10b5-1 −2,170 $27.38 $59,415 76,140 D
Derivatives
Rodman David Malcom Chief Medical Officer 2026-04-09 Option exercise · Stock Option 10b5-1 −2,170 21,706 D
Open-market sales · 2,170 sh · avg $27.38 · $59,415
Loading xslF345X06/wk-form4_1776129225.xml…